Aquestive Therapeutics, Inc. AQST Personnel costs — Total General and Administrative Expenses
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s personnel costs — total general and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s personnel costs — total general and administrative expenses?
- Aquestive Therapeutics, Inc. (AQST) reported personnel costs — total general and administrative expenses of $5.51M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s personnel costs — total general and administrative expenses changed year-over-year?
- Aquestive Therapeutics, Inc.'s personnel costs — total general and administrative expenses increased by 13.8% year-over-year, from $4.84M to $5.51M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s personnel costs — total general and administrative expenses?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s personnel costs — total general and administrative expenses has grown at a 35.7% compound annual growth rate (CAGR), from $10.77M to $19.83M.
- What does personnel costs — total general and administrative expenses mean?
- This metric measures the personnel costs for staff performing general corporate functions, including executive management, finance, legal, and human resources. It represents the overhead required to maintain the company's operational infrastructure and corporate governance. Analyzing this metric helps investors evaluate the company's ability to manage administrative overhead relative to its overall growth and revenue generation.